International Journal of Drug Policy
Volume 21, Issue 4 , Pages 276-282 , July 2010

Clean Olympians? Doping and anti-doping: The views of talented young British athletes

Received 2 September 2009 ,Revised 29 November 2009 ,Accepted 30 November 2009.

References 

  1. American Academy of Pediatrics . Adolescents and anabolic steroids: A subject review. Pediatrics. 1997;99:904–908
  2. Bahrke MS, Yesalis CE, Kopstein AN, Stephens JA. Risk factors associated with anabolic androgenic steroid use among adolescents. Sports Medicine. 2000;29(6):397–405
  3. Baker JS, Graham MR, Davies B. Steroid and prescription medicine abuse in the health and fitness community: A regional study. European Journal of Internal Medicine. 2006;17:479–484
  4. Bear GB, Uribe-Zarain X, Manning MA, Shiomi K. Shame, guilt, blaming, and anger: Differences between children in Japan and the US. Motivation and Emotion. 2009;33:229–238
  5. Beckett AH, Cowan DA. Misuse of drugs in sport. British Journal of Sports Medicine. 1979;12:185–194
  6. Bringer, J. (2002). Sexual exploitation: Swimming coaches’ perceptions and the development of role conflict and role ambiguity. Unpublished doctoral thesis, University of Gloucestershire.
  7. Calfee R, Fadale P. Popular ergogenic drugs and supplements in young athletes. Pediatrics. 2006;117(3):e577–e589
  8. Eisenberg N. Emotion, regulation, and moral development. Annual Review of Psychology. 2000;51:665–697
  9. Evans-Brown M, McVeigh J. Injecting human growth hormone as a performance-enhancing drug – perspectives from the UK. Journal of Substance Use. 2009;14(5):267–288
  10. Foddy B, Savulescu J. Ethics of performance enhancement in sport: Drugs and gene doping. In:  Ashcroft RE,  Dawson A,  Draper H,  McMillan J editor. Principles of healthcare ethics. 2nd edition. London: Wiley; 2007;p. 511–520
  11. Goldman B, Bush PJ, Klatz R. Death in the locker room. Indiana: Icarus Press Inc; 1984;
  12. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456:702–705
  13. Hoberman, J. (2004). A Pharmacy on Wheels – The Tour De France Doping Scandal. Available Online <http://www.thinkmuscle.com/ARTICLES/hoberman/tour.htm> Accessed 2nd November 2009.
  14. Hoffman ML. Empathy and moral development: Implications for caring and justice. Cambridge: Cambridge University Press; 2000;
  15. Howe PD. Sport, professionalism and pain: Ethnographies of injury and risk. London: Routledge; 2004;
  16. Kayser B, Smith ACT. Globalisation of anti-doping: The reverse side of the medal. BMJ. 2008;337:a584
  17. Kitzinger J. The methodology of focus groups: The importance of interaction between research participants. Sociology of Health and Illness. 1994;16(1):103–121
  18. Kitzinger J. Qualitative research: Introducing focus groups. BMJ. 1995;311:299–302
  19. Kreft L. The elite athlete – in a state of exception?. Sport, Ethics and Philosophy. 2009;3(1):3–18
  20. Laure P. In praise of the non-dominant senses of doping behaviour. In:  Møller V,  McNamee MJ,  Dimeo P editor. Elite sport, doping and public health. Odense: University Press of Southern Denmark; 2009;p. 119–134
  21. Laure P, Lecerf T, Friser A, Binsinger C. Drugs, recreational drug use and attitudes towards doping of high school athletes. International Journal of Sports Medicine. 2004;25:133–138
  22. Lee RM. Doing research on sensitive topics. London: Sage; 1993;
  23. Lippi G, Banfi G, Franchini M, Cesare Guidi G. New strategies for doping control. Journal of Sports Sciences. 2008;26(5):441–445
  24. Magdalinski T. Sport, technology and the body. London: Routledge; 2009;
  25. McAlinden L. The use of shame with sexual offenders. British Journal of Criminology. 2005;45(3):373–394
  26. McNamee, M. J., Bailey, R., Pearce, G., Bloodworth, A., & Sheridan, H. (2007). Anti-doping: Values and attitudes of talented young athletes. Phase I Report to UK sport, Unpublished manuscript.
  27. McNamee, M. J., & Bloodworth, A. J. (2009). Attitudes and values of talented young athletes towards doping and anti-doping policies and practices. Phase III Report made to UK Sport, Unpublished manuscript.
  28. McNamee, M. J., Bloodworth, A. J., & Calitri, R. (2008). Attitudes and values of talented young athletes towards doping and anti-doping policies and practices. Phase II Report made to UK Sport, Unpublished Manuscript.
  29. McNamee MJ, Olivier S, Wainwright P. Research ethics in exercise and health sciences. London: Routledge; 2006;
  30. Miah A. Genetically modified athletes. London: Routledge; 2004;
  31. Møller V. The doping devil. Odense: University of Southern Denmark Press; 2008;
  32. Møller V. The ethics of doping and anti-doping. London: Routledge; 2009;
  33. In:  Morris H editors. Guilt and shame. Belmont, CA: Wadsworth; 1971;
  34. Murphy JG. Shame creeps through guilt and feels like retribution. Law and Philosophy. 1999;18:327–344
  35. Petróczi A. Attitudes and doping: A structural equation analysis of the relationship between athletes’ attitudes, sport orientation and doping behaviour. Substance Abuse Treatment, Prevention, and Policy. 2007;2(34):
  36. Petróczi A, Aidman E. Psychological drivers in doping: The life cycle-model of performance enhancement. Substance Abuse Treatment, Prevention, and Policy. 2008;3:7
  37. Sahakian B, Morein-Zamir S. Professor's little helper. Nature. 2007;450:1157–1159
  38. Slater, M. (2009) Legal threat to anti-doping code. Available Online. <http://news.bbc.co.uk/sport1/hi/front_page/7844918.stm> accessed 2 November 2009.
  39. Tangney JP, Dearing R. Shame and guilt. New York: Guilford; 2002;
  40. Tangney JP, Stuewig J, Mashek DJ. Moral emotions and moral behavior. Annual Review of Psychology. 2007;58:345–372
  41. UK Sport. (2009). Anti-doping in the UK: What is doping? Available Online. <http://www.100percentme.co.uk/1162212006.747/?PHPSESSID=3e60c52171fceab504fb72e10a8745ec> accessed 2 November 2009.
  42. Vest Christiansen A. The legacy of Festina: Patterns of drug use in European cycling since 1998. Sport in History. 2005;25(3):497–514
  43. Vest Christiansen A. Doping in fitness and strength training programmes-politics, motives and masculinity. In:  Møller V,  McNamee MJ,  Dimeo P editor. Elite sport, doping and public health. Odense: University Press of Southern Denmark; 2009;p. 99–118
  44. Vest Christiansen A, Møller V. Mål, medicin og moral (Ambition medicine and ethic: On elite athletes perception of sport, doping and fair play). Odense: University of Southern Denmark Press; 2007;
  45. WADA. (2009a). World anti-doping code. Available Online. <http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/The-Code> accessed 29 November 2009.
  46. WADA. (2009b). World anti-doping agency: Education. Available Online. <http://www.wada-ama.org/en/Education-Awareness/> accessed 29 November 2009.
  47. Yesalis CE, Bahrke MS. Doping among adolescent athletes. Baillière's Clinical Endocrinology and Metabolism. 2000;14(1):25–35

PII: S0955-3959(09)00161-3

doi: 10.1016/j.drugpo.2009.11.009

International Journal of Drug Policy
Volume 21, Issue 4 , Pages 276-282 , July 2010

Article Tools